\BOOKMARK [1][]{section.1}{Table S1: Neuroblastoma classification according to the International Neuroblastoma Risk Group staging system}{}% 1
\BOOKMARK [1][]{section.2}{Table S2: Cox analysis of progression-free survival}{}% 2
\BOOKMARK [1][]{section.3}{Figure S1: HRNBL1 protocol}{}% 3
\BOOKMARK [1][]{section.4}{Figure S2: SIOPEN scoring}{}% 4
\BOOKMARK [1][]{section.5}{Figure S3: Primary tumor and metastases location}{}% 5
\BOOKMARK [1][]{section.6}{Figure S4: Simulations of all patients}{}% 6
\BOOKMARK [1][]{section.7}{Figure S5: Overall survival analysis in dichotomized groups}{}% 7
\BOOKMARK [1][]{section.8}{Figure S6: Progression-free survival analysis in dichotomized groups}{}% 8
\BOOKMARK [1][]{section.9}{Figure S7: Calibration plots}{}% 9
